探索儿科口服悬浮剂的开发:挑战,要求和配方进展
Sachin S Gaikwad1, Javier O Morales2, Narayan B Lande3
1Department of Pharmaceutics, Sanjivani College of Pharmaceutical Education and Research, Savitribai Phule Pune University, At Sahajanandnagar, Post-Shinganapur, Tal-Kopargaon, Ahmednagar, Maharashtra 423603, India; Department of Pharmaceutics, MET's Institute of Pharmacy, Affiliated to Savitribai Phule Pune University, Bhujbal Knowledge City, Adgaon, Nashik 422003, India.
由于固体药物的挑战,开发安全有效的儿科口服悬浮剂至关重要. 本综述强调了配方,助剂选择和表征的关键考虑因素,以确保成功的儿科疗法.
科学领域:
- 制药科学 制药科学
- 儿科药物输送 儿科药物输送
背景情况:
- 由于固体剂型的困难,小儿科患者更喜欢口服悬浮剂.
- 挑战包括吞问题,苦味,生物可用性差以及儿童的生理变异.
- 确保治疗成功需要安全有效的儿科口服悬浮剂.
研究的目的:
- 审查儿科口服悬浮剂开发的基本方面.
- 分析选择安全有效的辅助剂和防腐剂的考虑因素.
- 为了应对制定稳定,适合年龄的儿科悬浮剂的挑战.
主要方法:
- 文献审查侧重于儿科口服悬浮剂配方.
- 辅助剂和防腐剂选择标准的分析.
- 检查影响药物释放和儿科群体生物可用性的因素.
主要成果:
- 辅助剂的选择对于儿科口服悬浮剂的安全性,疗效和稳定性至关重要.
- 药物释放动力学显著影响口服吸收和生物可用性,特别是BCSII类药物.
- 为多样化的儿科年龄组制定一个单一的,稳定的悬浮剂提出了制定挑战.
结论:
- 仔细选择辅助剂和防腐剂对于儿科口服悬浮剂的开发至关重要.
- 优化药物释放特征可以提高生物可用性,并最大限度地减少儿童的不良影响.
- 需要进一步的研究来解决配方稳定性和特定年龄的药物动力学因素.
更多相关视频
04:28Utilizing an Orally Dissolving Strip for Pharmacological and Toxicological Studies: A Simple and Humane Alternative to Oral Gavage for Animals
Published on: March 23, 2016
05:45Author Spotlight: Process Development for the Spray-Drying of Probiotic Bacteria and Evaluation of the Product Quality
Published on: April 7, 2023
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Preclinical Development: Overview
Biopharmaceutics and Pharmacokinetics: Overview
